Infosys has been recognized as a Leader in the IDC MarketScape report, ‘Worldwide Life Science R&D ITO Services 2018 Vendor Assessment’. IDC rated Infosys highly for the value it delivers to its customers relative to cost, quality of its ITO work, and willingness to contribute strategically to operational efforts.
The IDC study is the second document of a three-part series (BPO, ITO, and strategic consulting) that examines IT outsourcing in the life science R&D space. With a specific focus on life science R&D ITO, this report compares 11 major IT service providers based on operational, business, and market-centric criteria that should be important to life science companies when considering the selection of an external service provider to take over non-core IT activities.
Infosys has been serving the life science industry for more than 13 years and has over 5,000 workforce dedicated to its life science practice. Within the life science and R&D ITO space, Infosys is strong in delivering data and applications development and management, technology infrastructure and cloud implementation and support, and testing services to its clients. The extensive network of delivery centers also enables Infosys to offer its customers flexibility for project engagements. According to IDC, while growing its efforts with eminent pharmaceutical companies, Infosys has created a significant industry footprint that appeals to companies of all sizes.
